Specific gene transfer only to the site of placentation without affecting the fetus.
For acute kidney injury, inflammatory bowel disease, depressions, etc.
Therapeutic target molecules and antisense oligonucleic acid (ASO) therapeutic agents for autosomal dominant polycystic kidney disease (ADPKD).
Peptide linker enhances the interaction between VH-VL within scFv molecules, which suppresses intermolecular association.
A novel therapeutic approach for systemic anti-tumor immunity utilizing apolipoproteins
Splice-switching antisense oligonucleotides (SSOs) targeting the α-synuclein (SNCA) gene suppress α-synuclein (α-Syn) aggregation.
Discovery of Induction Method from Dental Pulp Cells to Odontoblasts
ASO-4733: Optimized Anti-SYT13 antisense oligonucleotides
This system has the capability to recognize human brain activity through the execution of time series analysis on brain signals, enabling the diagnosis of neurodegenerative diseases such as Alzheimer's and the estimation of specific motor movements.